Tesla Cybercab Launch Puts Robotaxi Ambitions in Focus 
ByteDance Secures $29.6 Billion Loan to Boost AI Investment 
Lenovo Shares Fall After Dropbox Security Breach Exposes ID Vulnerability 
Volkswagen Approves 50,000 More Job Cuts in Major Restructuring 
BP Names Ian Tyler Permanent Chairman After Governance Shake-Up 
OpenAI Launches GPT-6 Astra With Advanced AI Agent Capabilities 
South Korea, US Discuss Chip Investments Amid Tariff Plans 
Qantas Near-Miss Raises Sydney Air Traffic Controller Fatigue Concerns 
Fast Retailing Shares Drop as Uniqlo Japan August Sales Fall 
Xiaomi Shares Jump on Europe EV Expansion Plan 
Honda Targets $9.4 Billion in Cost Cuts as China EV Competition Intensifies 
Audi, SAIC Launch China Innovation Hub for New AUDI Models 
Tesla Cybercab Rides Launch in Austin as NHTSA Reviews Rollout 
Nvidia Eyes $2.5 Billion Investment in Thinking Machines Lab 
SpaceX Turbine Push Unlikely to Threaten Howmet, Bernstein Says 
Deutsche Telekom Shares Rise as Elliott Pushes Against T-Mobile Merger 
Milei Threatens Falkland Oil Firms With Sanctions 
Add as a preferred source on Google
Dublin, Feb. 26, 2018 -- The "Therapeutic Drug Monitoring - Technologies, Markets, and Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering.
This report deals with therapeutic drug monitoring, a multi-disciplinary clinical specialty, aimed at improving patient care by monitoring drug levels in the blood to individually adjust the dose of drugs for improving outcome.
TDM is viewed as a component of personalized medicine that interacts with several other disciplines including pharmacokinetics and pharmacogenetics. One chapter is devoted to monitoring of drugs of abuse (DoA). Various technologies used for well-known DoA are described.
A section on drug abuse describes methods of detection of performance-enhancing drugs. TDM market is analyzed from 2016 to 2026 according to technologies as well as geographical distribution. Global market for DoA testing was also analyzed from 2016 to 2026 and divided according to the area of application. Unmet needs and strategies for development of markets for TDM are discussed.
The report contains profiles of 35 companies involved in developing tests and equipment for drug monitoring along with their collaborations. The text is supplemented with 21 tables, 9 figures and 210 selected references from literature.
Key Topics Covered:
Executive Summary
1. Introduction
2. Technologies for TDM
3. Drug Monitoring Instruments
4. Applications of TDM
5. Drugs Requiring Monitoring
6. Monitoring of Biological Therapies
7. Monitoring of Drug Abuse
8. Markets for TDM
9. Companies
10. References
For more information about this report visit https://www.researchandmarkets.com/research/dsrx37/global?w=12
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Discovery
